BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-ana
| Current Price | ₹351.45 |
|---|---|
| Market Cap | ₹202 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 18.7 |
| Return on Equity | 14.84% |
| 52-Week Range | ₹248.75 – ₹523.75 |
| Beta (1Y) | 0.54 |
| Dividend Yield | 1.42% |
1. Pharmaceuticals-99.1% 2. Renewable Energy-0.9%
Bdh Industries Ltd. is trading at ₹351.45, with a market capitalisation of ₹202 Cr.
Bdh Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Bdh Industries Ltd. has a P/E of 18.7 and a return on equity of 14.84%.